Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
105
Share
QR code
Edit Profile
James Galvin
INTEGRATED MEDICAL SCIENCE | CHARLES E. SCHMIDT COLLEGE OF MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Stories
Websites
Contact
All
Research
Publications
Stories
Websites
Contact
Research Terms & Keywords
Research Terms
Medical Sciences
Industries
Health Care
Research Projects
Ends
Title
12-2019
Reducing Disability via a Family-centered Intervention for Acutely-Ill Persons with Dementia
Reducing Disability via a Family-centered Intervention for Acutely-Ill Persons with Dementia
Pennsylvania State University - Fed Flow
09-2019
LBDA Research Center of Excellence Award
LBDA Research Center of Excellence Award
Lewy Body Dementia Association - Other
06-2019
A randomized, double-blind, placebo-controlled, two cohort parallel group study to evaluae the efficacy of CAD106 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s
A randomized, double-blind, placebo-controlled, two cohort parallel group study to evaluae the efficacy of CAD106 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s
Novartis - Corp.
06-2019
A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed with Behavioral Variant Frontotemporal Dementia and Healthy Subjects
A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed with Behavioral Variant Frontotemporal Dementia and Healthy Subjects
Quintilies/Biogen MA - Corporation
03-2019
FoxBioNet LRRK2-002
FoxBioNet LRRK2-002
The Michael J.Fox Foundation for Parkinson's Research
12-2018
The Leo and Anne Albert Charitable Trust Support for Dementia Prevention
The Leo and Anne Albert Charitable Trust Support for Dementia Prevention
FAU Foundation
09-2018
Biomarkers for Lewy Body Dementia
Biomarkers for Lewy Body Dementia
Cleveland Clinic - Federal Flow Through
08-2018
DEMENTIA PREVENTION INITIATIVE: A Personalized Approach to Dementia Prevention
DEMENTIA PREVENTION INITIATIVE: A Personalized Approach to Dementia Prevention
FAU Foundation
07-2018
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
New York University Schl. of Medicine - Federal Flow Through
06-2018
Biogen 221AD302
Biogen 221AD302
Quintiles/Lilly Research Laboratories - Corp.
05-2018
Escitalopram for Agitation in Alzheimer’s Disease Research Group (S-CitAD)
Escitalopram for Agitation in Alzheimer’s Disease Research Group (S-CitAD)
Johns Hopkins University-Federal Flow Through
03-2018
A Multi-Site Cluster RCT of the Dementia Symptom Management At Home Program
A Multi-Site Cluster RCT of the Dementia Symptom Management At Home Program
New York Univ.-RM College of Nur. - Federal Flow Through
03-2018
RVT-101-2002: A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Dementia with Lewy Bodies (DLB)
RVT-101-2002: A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Dementia with Lewy Bodies (DLB)
Axovant Sciences Ltd.- Other
02-2018
A Phase 2b/3, Randomized...Protocol #54861911ALZ2003
A Phase 2b/3, Randomized...Protocol #54861911ALZ2003
Janssen Research & Development, LLC - Corporation
01-2018
Caring For You (C4U): A Novel Intervention to Improve Caregiver and Patient Outcomes
Caring For You (C4U): A Novel Intervention to Improve Caregiver and Patient Outcomes
Florida Department of Health - State
01-2018
RVT-101-2001, A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB)
RVT-101-2001, A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB)
Axovant Sciences Ltd.- Other
10-2017
RVT-102-2003: An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
RVT-102-2003: An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
Axovant Sciences Ltd.- Other
07-2017
RVT-102-2002: A Phase 2, double-blind, randomized, placebo-controlled study of nelotanserin versus placebo in patients with dementia with Lewy bodies (DLB) experiencing REM sleep behaviors (RBD)
RVT-102-2002: A Phase 2, double-blind, randomized, placebo-controlled study of nelotanserin versus placebo in patients with dementia with Lewy bodies (DLB) experiencing REM sleep behaviors (RBD)
Axovant Sciences Ltd.- Other
12-2016
The Social and Economic Burden of Frontotemporal Degeneration
The Social and Economic Burden of Frontotemporal Degeneration
Association for Frontotemporal Degeneration-Association
Publications
Search Engines
Search Google Scholar for James Galvin
Stories
“Curved Walking” May Help Identify Early Cognitive Decline
#CurveMC
“Curved Walking” May Help Identify Early Cognitive Decline
#CurveMC
Websites
Search Google Scholar for James Galvin
Contact Information
galvinj@health.fau.edu
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
